In this work, a new class of antibody mimics was evaluated; specifically, the ‘megamolecule’ platform developed in our laboratory, where synthesized ligands react with recombinantly expressed fusion proteins to create multi-component, complex architectures…
Speakers
HHMI/Northwestern University